跳至主要内容
临床试验/IRCT20110811007297N7
IRCT20110811007297N7招募中2 期

Efficacy and Safety of Crocin Supplementation in Patients With Central SerousChorioretinopathy (CSCR)

Shiraz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • age of 18-60 years old
  • The diagnosis of CSCR based on clinical and imagining evaluation
  • informed consent

排除标准

  • Chronic Central SerousChorioretinopathy (CSCR)
  • Laser treatment (6 months prior to enrollment)
  • Intravitreal injection (3 months prior to enrollment)
  • Other retinal diseases
  • History of eye diseases
  • Diabetes Mellitus
  • Renal or hepatic diseases
  • Allergy to saffron or crocin
  • Pregnancy or lactation
  • Beta-blocker, diuretic, or corticosteroid (1 week prior to enrollment)
  • Bleeding tendency or any coagulation disorder

研究者

相似试验